"Performance" HAOHAI BIOTEC earned 305 million RMB in the first three quarters, a decline of 10.6%

HAOHAI BIOTEC (06826.HK) announced its third-quarter report for the period ending in September, achieving operating revenue of 1.899 billion RMB (the same below), a year-on-year decrease of 8.5%. The net profit attributable to shareholders was 305 million RMB, a decline of 10.6%, with earnings per share of 1.31 RMB